HDAC1 and central nervous system cancer: We found that, for both genes, copy number deletions were associated with lower mRNA expression, and in gliomas without HDAC1 or SIRT2 copy number variations, patients with lower HDAC1 expression or higher SIRT2 expression showed better clinical prognosis.